|
Volume 271,
Number 16,
Issue of April 19, 1996 pp. 9320-9325
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Enhancement of
Protein Kinase C-dependent O Production
in Epstein-Barr Virus-transformed B Lymphocytes by p120 Antisense Oligonucleotide (*)
(Received for publication, October 10,
1995; and in revised form, January 10, 1996)
Elmar
Schmid (§),
,
James A.
Koziol
,
Bernard
M.
Babior
From the Department of Molecular and Experimental Medicine, The Scripps
Research Institute, La Jolla, California 92037
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The mammalian Ras GTPase-activating protein
(p120 ) interacts with activated members of the Ras
superfamily of GTP-binding proteins to accelerate their deactivation by
sharply increasing their rates of GTP hydrolysis. Among the Ras-family
proteins interacting with p120 is Rap1A/Krev1, whose
activity is not affected by p120 but which competes
with Ras for p120 . A second protein that interacts
with p120 is p190 , which activates
the GTPase of guanine nucleotide-binding proteins of the Rho family
(including Rac1 and Rac2). Both these p120 -binding
proteins are of interest in connection with the regulation of the
respiratory burst oxidase, Rap1A/Krev1 because it copurifies with
cytochrome b , and p190 because
it inhibits the Rac2-dependent activation of the respiratory burst
oxidase in a cell-free system. Using an 18-mer antisense
oligonucleotide, we were able to decrease the expression of
p120 in Epstein-Barr virus-transformed B lymphocytes.
Under conditions where p120 expression was
significantly depressed by antisense oligonucleotides, we observed a
40% increase in protein kinase C-dependent but not receptor-dependent
O production. In contrast, sense and
scrambled oligonucleotides had no effect on either
p120 expression or O production. Our results suggest a role for p120 as a negative regulator in the protein kinase C-mediated
activation of the respiratory burst oxidase.
INTRODUCTION
The products of the mammalian N-, K-, and Ha-ras genes are 21-kDa guanine nucleotide-binding proteins
that possess a low intrinsic GTPase activity(1, 2) .
They play a significant role in both the control of normal cell growth (3) and its malignant subversion (4) and have been
implicated as key elements in signal transduction in lymphoid and
myeloid cell lines(5, 6, 7) . The activity of
Ras depends on the ratio of bound GTP to GDP, a value that is
determined by certain regulatory proteins: guanine nucleotide exchange
factors such as Sos (8) and Vav(9) , which activate Ras
by catalyzing the exchange of bound GDP for GTP, and GTPase-activating
proteins such as the NF-1 gene product (10) and
p120 , which deactivate Ras by stimulating the
conversion of bound GTP to GDP(11) . p120 is a monomeric 120-kDa cytosolic protein that greatly accelerates
the conversion of p21 GTP to the conformationally
inactive GDP-bound form(12, 13) . Accordingly,
p120 has been proposed as a negative regulator of Ras
in cellular processes. This proposal is consistent with the finding
that overexpression of p120 blocks oncogenic
transformation (14, 15) and inhibits Ras-dependent
cellular signaling(16) . In addition, since the site of
interaction of p21 GTP with p120 overlaps the effector region of Ras, it has been proposed that
p120 may also serve as an effector protein of active
Ras(17, 18) . p120 consists of a
C-terminal domain that interacts with Ras and an N-terminal portion
containing two Src homology (SH2) domains and one intervening SH3
domain (reviewed in (19) ). The
p21 GTP-p120 complex may interact
with downstream effectors via these Src-homology domains. SH2 domains
bind phosphotyrosine residues and have been implicated in the
interactions of tyrosine kinases of the Src family with their effector
proteins(20, 21) . Several members of the Src family
of protein-tyrosine kinases (e.g. c-Src and Lck) have been
shown to associate with and phosphorylate
p120 (22, 23, 24) . In
fibroblasts transformed by cytoplasmic and receptor-like tyrosine
kinases(25) , p120 forms complexes with two
phosphotyrosine-containing proteins, p62 and p190 .
The complex with p62 appears to involve the SH2 domains of
p120 (26, 27) , and the formation of
the p120 -p190 complex is dependent
on phosphorylation(28) , suggesting that it too involves the
p120 SH2 domains. The complex itself has diminished
p120 activity in vitro(28) .
Tyrosine-phosphorylated p62 and p190 have been
detected in anti-p120 immunoprecipitates from various
activated or transformed B- and T-cell lines(30, 31) ,
and were proposed to participate in signal transduction in these cells.
The p120 -associated p190 stimulates
the intrinsic GTPase activity of Rac1 and Rac2, which are Rho family
guanine nucleotide-binding proteins(32) . In human phagocytes,
Rac2 plays a significant role in the activation of the respiratory
burst oxidase(33, 34, 35) . The human oxidase
consists of two membrane-bound components (gp91 and p22 ) and at least three
cytosolic components (p47 ,
p67 , and Rac2) that after cellular activation
assemble to form the active enzyme (reviewed in (36) ).
p190 has been shown to inhibit the Rac2-dependent
activation of the respiratory burst oxidase in a cell-free
system(37) , pointing to a role for this
p120 -associated protein in the regulation of the
oxidase. The same oxidase has also been found in normal human B-cells
and EBV-transformed ( )B
lymphocytes(38, 39) , and Rac2 plays a significant
role in the activation of the lymphocyte oxidase(33) . Since we
were able to detect p190 in p120 immunoprecipitates from cultured EBV-transformed B lymphocytes
and since there have been several reports of the use of antisense
oligonucleotides in these cells (33, 40, 41) , we used antisense
oligonucleotides to study the effects of p120 (and
possibly associated proteins) on O production. In this report we describe the results of this study.
MATERIALS AND METHODS
ReagentsRPMI 1640 medium was purchased from
Bio-Whittaker (Walkersville, MD). Hanks' balanced salt solution
(HBSS), cysteine/methionine-free DMEM, DMEM, and Opti-MEM medium were
from Life Technologies, Inc. Fetal calf serum was purchased from
Hyclone Laboratories (Logan, TN). Glutamine, fungizone, luminol,
leupeptin, aprotinin, pepstatin and phenylmethylsulfonyl fluoride were
from Sigma. The monoclonal anti-p120 antibody was
obtained from UBI (Lake Placid, NY). Rabbit polyclonal
anti-p47 or p67 antibodies raised against
peptide sequences of these proteins were used as described
previously(29, 42) . Pansorbin (dried protein
A-positive Staphylococcus aureus, Cowan I strain), GF109203X
(GFX; a relatively specific inhibitor of protein kinase C), ionomycin
(a Ca ionophore), and horseradish peroxidase were
from Calbiochem. Protein G-agarose beads (protein G-Sepharose) were
purchased from Pharmacia (Uppsala, Sweden). Tran S-label
was from ICN (Irvine, CA).
Cell Culture and Incubation with
OligonucleotidesThe human EBV-transformed B lymphocyte cell
line EW was a generous gift from Dr. Peter Newburger (University of
Massachusetts School of Medicine). Cultures were maintained under
subconfluent conditions in RPMI 1640 supplemented with 10%
heat-inactivated (55 °C, 30 min) fetal calf serum, 2 mM glutamine, and fungizone. Cells were kept in a humidified
incubator at 37 °C under 6% CO . Viability of the
lymphoblastoid cells was routinely >90% as determined by trypan blue
exclusion. An 18-mer antisense oligodeoxynucleotide sequence
complementary to a sequence spanning the published ATG initiation
region of the human p120 message (43) was
designed with the help of the OLIGO program (45) to optimize
for sites with maximum melting temperature with minimum
self-complementarity and minimum dimer formation. Unmodified
oligodeoxynucleotides with the antisense sequence
5`-GCCATCATGTTGAAGCCG-3`, the corresponding sense sequence
5`-CGGCTTCAACATGATGGC-3`, and a scrambled sequence designed using a
random number generator (5`-CACGTACGGCTAAGTGCT-3`) were synthesized in
the core lab facility of The Scripps Research Institute and purified by
twice precipitating them from 0.5 M NaCl with ethanol. Their
purity was routinely checked by analytical reversed phase HPLC (C8
column, 0.1-50% acetonitrile in 100 mM triethylammonium
acetate, pH 7.0), detecting at 260 nm. Analytical 19% urea-PAGE (44) showed that >90% of the oligonucleotides were full
length.Low passage cells ( )were washed 3 times in
Opti-MEM and then incubated with 0.1 mM oligonucleotides for
24 h in serum-free Opti-MEM at a starting cell density of 4
10 /ml. The cells were then washed once in HBSS and used
either for immunoblotting or for the measurement of
O production.
Stability of OligonucleotidesThe stability of the
oligonucleotides under the chosen incubation conditions in the presence
and absence of cells was evaluated by HPLC. For this purpose, 50
µM oligonucleotide was incubated at 37 °C in
serum-free Opti-MEM medium with or without 5 10 EBV-transformed lymphocytes under tissue culture conditions. At
the times indicated, 0.5-ml portions of incubation mixture were
withdrawn, and DNA was purified by extracting twice with
phenol/chloroform. After washing twice with ether, 0.2-ml portions of
the aqueous layers were analyzed by HPLC as described above. The
quantity of oligonucleotide was determined from the peak height. In
every case, the mobility of the extracted oligonucleotide was identical
to that of the unincubated oligonucleotide.
ImmunoblottingAfter culture for 24 h in the
presence of oligonucleotide, the cells were isolated by centrifugation
(12,000 g, 30 s at room temperature) and then lysed by
incubation for 15 min on ice in Triton lysis buffer (25 mM HEPES (pH 7.5) containing 150 mM NaCl, 1% Triton X-100,
10% glycerol, 2 mM EDTA, 2 mM EGTA, 10 µg/ml
leupeptin, 10 µg/ml aprotinin, 5 µg/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride). The lysates were centrifuged for
15 min at 13,000 g, and the supernatants were assayed
for protein content using the micro-BCA protein assay (Pierce).
p120 was isolated from supernatants containing equal
quantities of protein either by acetone precipitation (2 volumes of
acetone (2-4 h at -20 °C) followed by centrifugation)
or by immunoprecipitation (monoclonal anti-p120 antibody and protein G-Sepharose beads, washing the
immunoprecipitates 3 times with Triton lysis buffer before release from
the beads). The precipitated proteins were dissolved by boiling in
Laemmli sample buffer and then separated by SDS-PAGE (7.5% gel, Laemmli
buffer) and subjected to immunoblotting to detect p120 (monoclonal anti-p120 at 1:2000 dilution) and
oxidase subunits (rabbit polyclonal anti-p47 at 1:5000
dilution and anti-p67 at 1:1000 dilution), using the
oxidase subunits as standards for protein loading. The proteins were
visualized with alkaline phosphatase-conjugated goat anti-mouse or
anti-rabbit antibodies with nitro blue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate as phosphatase
substrate. Experiments in which antisense p120 levels
were not diminished as compared with sense and scrambled
p120 levels were disregarded.
Turnover of p120 in EBV-transformed B
LymphocytesEBV-transformed B lymphocytes were washed 3 times in
methionine/cysteine-free DMEM (DMEM-) and then incubated in the
same buffer supplemented with 10 mM HEPES for 30 min at 37
°C. The cells were then isolated by centrifugation, suspended in
DMEM- plus Tran S-label (0.2 mCi/ml), and incubated
for a further 60 min at 37 °C. The radiolabeled cells were then
washed in complete DMEM (DMEM plus cysteine/methionine) and cultured in
complete DMEM containing 5% fetal calf serum. At the intervals noted,
1-ml portions of the culture were withdrawn, and the cells were
isolated by centrifugation and then lysed by suspension in Triton lysis
buffer. p120 in the lysates was immunoprecipitated as
described above. The washed immune complexes were resuspended in
Laemmli sample buffer, and the proteins were separated by 7.5%
SDS-PAGE. After electroblotting on nitrocellulose, the quantities of
p120 in the different samples were established as
approximately equal by immunoblotting (see above), and the amount of S in each p120 band was measured with a
phosphor imager.
Measurement of O ProductionAfter incubation in the presence of the
oligonucleotides, the lymphoblasts were isolated by centrifugation,
washed once in HBSS, and resuspended in prewarmed (37 °C) HBSS
containing 1 mM CaCl and 1 mM MgCl . Viability of the resuspended cells as determined
by trypan blue exclusion was >90%, a value not different from that
obtained with untreated cells. After counting the cells and determining
their viability, 2 10 live cells from each
incubation were transferred to 96-well microtiter luminescence plates
(Labsystems Inc.) and prewarmed at 37 °C. After 5 min, luminol (10
µM final concentration), horseradish peroxidase (50
µg/ml), and either phorbol myristate acetate (1 µg/ml),
Pansorbin (Calbiochem) (1 mg/ml), or ionomycin (0.1 µg/ml) as
indicated were added to each well, yielding final incubation mixtures
of 250-µl volume. Chemiluminescence from each well was then
recorded at 37 °C over 10 consecutive 1-min intervals, using the
``repeatscan'' mode of a microplate luminometer (Labsystems
Luminoskan RS, Helsinki, Finland) and collecting data for 0.8 s. The
results were reported as relative luminescence units.
RESULTS
Using a monoclonal antibody against human
p120 , we were able to immunoprecipitate
p120 , together with the associated
tyrosine-phosphorylated proteins p62 and p190 , from
resting and stimulated EBV-transformed B-cells (data not shown).
Blotting of cell lysates with antibodies against p120 and the oxidase components p47 and p67 showed that p120 could be easily detected in
lysates of even small amounts of cells (<5 10 ).
The t for the turnover of p120 was 8-12 h, as measured in pulse-chase experiments with S-labeled cysteine/methionine (Fig. 1). In view of
this observation and reports that oligonucleotides are readily taken up
by EBV-transformed B lymphocytes (33, 40, 41) we decided to use antisense
oligonucleotides to study the effect of p120 on the
respiratory burst oxidase activity in this cell type.
Figure 1:
Turnover of
p120 in EBV-transformed B lymphocytes. The t for p120 was determined as
described under ``Results.'' Top, a representative
immunoblot showing p120 precipitated from aliquots of
cultured cells at various times. Bottom, S in the
immunoprecipitated p120 . The results show the amount
of S present at each time point, expressed as a fraction
of the amount of S present at 0 time (mean ± 1
S.E.; n = 3). Radioactivity at zero time was 42,700
± 1300 counts/24 h (S.D.).
Subconfluent
B-cell cultures were cultured without serum for 24 h in the presence of
p120 -specific antisense, sense, or scrambled
oligonucleotides. The cells were then assayed for 1) expression of
p120 , and 2) O production. In preliminary experiments with oligonucleotides
end-labeled with P, we showed that the added
oligonucleotides were taken up by the cells in a time-dependent
fashion, with maximum uptake at 4 h as previously reported (40) (data not shown). In addition, we found by HPLC that the
oligonucleotide was not significantly degraded after culture for 24 h
in medium alone and that even when cultured in the presence of the
cells 20% of the oligonucleotide initially added was present after
24 h (Fig. 2).
Figure 2:
Stability of oligonucleotides in culture.
Experiments were conducted as described in the text. Left,
representative HPLC tracings of antisense oligonucleotide incubated
with cells for 0 (above) and 8 (below) h. In each trace, the broad asymmetric peak on the left represents phenol, and the sharp peak on the right is the oligonucleotide. Right, oligonucleotide levels as
a function of time. Three incubations were conducted in the absence of
cells, and two were conducted in the presence of cells. The results are
presented as the mean ± S.E. of the values at zero time. A at zero time was 0.31 ± 0.13 and 0.68
± 0.23 for incubations carried out in the absence and presence
of cells, respectively.
When the cells were incubated for 24 h in the
presence of the antisense oligonucleotide, expression of
p120 was inhibited (Fig. 3). Immunoblots of
cells treated with the antisense oligonucleotide showed a substantial
reduction in the level of p120 as compared with
untreated cells or cells treated with sense or scrambled
oligonucleotides. By contrast, the levels of p47 and
p67 were not significantly altered by incubation with
antisense oligonucleotide, as revealed by parallel immunostaining of
blots with specific antibodies against these two proteins. These
results indicated that the suppression of p120 expression by the antisense oligonucleotide was specific and did
not affect the expression of two irrelevant proteins related to the
respiratory burst oxidase in this cell type.
Figure 3:
Effect of p120 antisense
oligonucleotide on p120 expression in EBV-transformed
B lymphocytes. EBV-transformed B lymphocytes were incubated for 24 h
with 0.1 mM antisense (A), sense (S), or
scrambled (SC) oligonucleotide. Cell proteins were then
precipitated with acetone and analyzed by SDS-PAGE and immunoblotting
as described in the text, probing with anti-p120 (1:2000), anti-p47 (1:5000), and
anti-p67 (1:1000) as indicated. The immunoblot
shown here is representative of blots from nine separate
experiments.
O production by EBV-transformed
B-cells treated with antisense, sense, or scrambled oligonucleotides
was detected by luminol-enhanced chemiluminescence of cells stimulated
with phorbol, Pansorbin, or ionomycin. When antisense-treated cells
were stimulated with phorbol we observed a significant enhancement of
O release in comparison with cells
preincubated with sense or scrambled sequences (Fig. 4, top). This enhancement always correlated with a reduced
expression of p120 and was not observed in cells
incubated in the presence of the oligonucleotide for 3 days, conditions
under which the expression of p120 had returned to
levels seen after incubation with sense or scrambled oligos (data not
shown). At 10 min, burst enhancement averaged 147 ± 10% (S.E.)
in cells treated with 0.1 mM antisense oligonucleotide. When
O formation was triggered by Pansorbin,
however, which acts through the cell's surface immunoglobulin
receptors, the burst-enhancing effect of antisense oligonucleotides was
not seen (Fig. 4, middle).
Figure 4:
Effect of p120 antisense
oligonucleotide on O production by
EBV-transformed B lymphocytes. Cells pretreated for 24 h with
oligonucleotides as indicated were stimulated with phorbol (top), Pansorbin (middle), or ionomycin (bottom). O production was
determined as luminol-enhanced chemiluminescence as described under
``Materials and Methods.'' Each point represents the
mean ± S.E. from five (phorbol, Pansorbin) or four (ionomycin)
separate experiments. Controls for the phorbol-, Pansorbin-, and
ionomycin-stimulated cells were the 10, 10, and 8 min scrambled
oligonucleotide values, respectively. Absolute values for control
relative luminescence units at these time points, expressed as
Luminoskan units, were 2.05 ± 0.05 for phorbol-stimulated cells,
0.49 ± 0.15 for Pansorbin-stimulated cells, and 0.64 ±
0.10 for ionomycin-treated cells (mean ± S.E.), respectively. No
light was emitted by unstimulated cells. By analysis of variance,
differences between antisense versus scrambled and antisense versus sense results were significant for phorbol-treated and
ionomycin-treated cells (p < 0.01 for all four comparisons)
but were not significant for Pansorbin-treated cells. ,
antisense; , sense; , scrambled.
O production by Pansorbin-treated
cells was much lower than that of phorbol-treated cells. To determine
whether the difference in the effect of antisense oligonucleotides on
phorbol-stimulated versus Pansorbin-stimulated cells was due
to the weakness of the latter stimulus, antisense experiments were
carried out on cells treated with ionomycin, another weak stimulus.
Experiments with the protein kinase C inhibitor GFX showed that
ionomycin, like phorbol but unlike Pansorbin, activated
O production by EBV-transformed B
lymphocytes through a protein kinase C-dependent mechanism (Fig. 5). Although levels of O production in response to ionomycin were similar to those seen
with Pansorbin, enhanced O production
in response to ionomycin was increased to 133 ± 8% (S.E.) of
control by the antisense oligonucleotide.
Figure 5:
Effect of the protein kinase C inhibitor
GFX on phorbol-, ionomycin-, and Pansorbin-triggered
O formation by EBV-transformed B
lymphocytes. Cells were preincubated with 0.5 µM GFX for 5
min at 37 °C and then stimulated with phorbol, ionomycin, or
Pansorbin as described under ``Materials and Methods.''
O production was determined as
luminol-enhanced chemiluminescence as described under ``Materials
and Methods.'' The results represent the mean ± S.E. of
four separate experiments, expressed as relative Luminoskan units.
, control; &cjs2113;, GFX.
p120 has
been connected to tyrosine kinase-mediated signaling pathways, where it
is thought to function downstream of activated Src-like protein
tyrosine kinases or growth factor receptor tyrosine
kinases(49, 56) . In T-cells, p120 is bound to Lck and becomes specifically phosphorylated by this
Src-like tyrosine kinase(23) . Since Lck has been reported to
play a significant role in EBV-induced growth of transformed B
lymphocytes(40) , and since antisense oligonucleotides against
Lck inhibited the growth of EBV-transformed B-cells, we examined the
effects of the p120 antisense oligonucleotide on this
parameter. We found that when p120 expression was
significantly reduced, the cell count after 24 h was low (Fig. 6). Despite this decrease in cell proliferation,
O production was increased in cells
incubated with the antisense oligonucleotide.
Figure 6:
Effect of p120 antisense
oligonucleotide on cell counts in cultures of EBV-transformed B
lymphocytes. Cells were cultured in the presence of various
oligonucleotides as described under ``Materials and
Methods.'' After 24 h in culture, the cells were isolated by
centrifugation (2000 g for 3 min at room temperature),
resuspended in Hanks' balanced salts solution, evaluated for
viability, and counted in a hemocytometer. The results represent the
mean ± S.E. of five separate experiments. For evaluating the
significance of differences between experimental and control cultures
(the controls were the cultures containing scrambled oligonucleotide), p values as determined by a paired t test are shown
in the figure.
DISCUSSION
Antisense strategy is a useful approach for elucidating the
role of different proteins in signal transduction(46) . Using
an 18-mer antisense oligonucleotide spanning the start codon of the
p120 message, we examined the function of
p120 in the control of respiratory burst oxidase
activity in EBV-transformed B lymphocytes. In agreement with Cheung and
Dosch(40) , we observed that these cells took up
oligonucleotides in a time-dependent fashion and that the antisense
oligonucleotide, but not the sense or scrambled oligonucleotide, was
able to reduce the expression of p120 . When
p120 expression was reduced,
O production by phorbol-and
ionomycin-stimulated lymphocytes increased, although
O production by protein A
(Pansorbin)-stimulated cells remained unchanged. Both phorbol- and
ionomycin-stimulated O production, but
not the Pansorbin-triggered burst, appear to be dependent on the
activation of protein kinase C, as indicated by results obtained with
GFX. The antisense results, therefore, point to a specific role for
p120 in the protein kinase C-dependent activation of
the respiratory burst oxidase in EBV-transformed B-cells. Several
laboratories have presented evidence showing a link between
p120 and protein kinase C-dependent signaling
pathways. In T-cells, an increase in the amount of active p21 that was induced by phorbol but not by receptor-dependent stimuli
has been related to a protein kinase C-mediated inactivation of
p120 (7) . In fibroblasts, overexpression of
p120 inhibited the activation of mitogen-activated
protein kinase by phorbol but not by receptor-dependent
stimuli(16) , presumably by causing a selective blockade of
signals from activated protein kinase C due to the inactivation of
p21 . Thus, for both cell types, p120 has been proposed as a negative regulator in a protein kinase
C-dependent signaling pathway. Our results point to a similar role for
p120 as a down-regulator of a protein kinase
C-dependent signaling pathway leading to an activated NADPH-oxidase. Among the factors that regulate the activity of small guanine
nucleotide-binding proteins is p190 , a 190-kDa
protein that accelerates the deactivation of guanine nucleotide-binding
proteins of the Rho class(32) . p190 is of
interest in regard to oxidase activation because Rac2, one of its
targets, is known to participate in the activation of the respiratory
burst oxidase both in the cell-free system (47, 48) and in whole cells(33) . In accord
with this idea, p190 was shown to inhibit
Rac2-dependent oxidase activation in the cell-free system (37, 49) . p190 is known to
associate with p120 in many cell types (25, 26, 30, 49) and using
anti-phosphotyrosine antibodies, we found a phosphorylated 190-kDa
protein, which could be identified as p190 , in
immunoprecipitates of p120 from EBV-transformed B
lymphocytes (data not shown). The possibility therefore exists that the
deficiency of p120 induced by the antisense
oligonucleotide resulted in a deficiency of p190 ,
leading to persistent oxidase activity due to a delay in the
deactivation of Rac2. Unfortunately, we were unable to detect
p190 on Western blots of extracts from
oligonucleotide-treated cells, so we have no direct evidence as to the
effect of the antisense oligonucleotide on p190 concentrations in the transformed lymphocytes. However, our
finding that phorbol-dependent but not receptor- (i.e. Pansorbin-) dependent oxidase activation is affected by the
antisense oligonucleotide is difficult to explain on the basis of an
indirect effect of p120 mediated through
p190 , because Rac2 is involved in both phorbol- and
receptor-mediated activation of the respiratory burst oxidase (33) so that an effect occurring via p190 should have involved both phorbol-activated and
receptor-activated O production. The
results therefore suggest a direct effect of p120 on
the oxidase activation cascade. Rap1A is a member of the Ras
superfamily of guanine nucleotide-binding proteins. Its participation
in the regulation of oxidase activity is suggested by its
copurification with cytochrome b (50) and by the finding that overexpression of Rap1A
mutants fixed in either the active or inactive conformation decrease
oxidase activity in transfected B lymphocytes(51) . Since
p120 has been shown to interact with the putative
effector region of rap1A in vitro(52) ,
p120 could participate in the physiological
regulation of Rap1A by competitively interfering with its deactivation
by Rap1-GAP, an 85-95-kDa Rap1-specific GTPase-activating protein (53) . Accelerated deactivation of Rap1A in the
p120 -depleted cell could therefore account for the
effect of the antisense oligonucleotide on oxidase activity. Whether a
mechanism based on Rap1A deactivation could account for the difference
between phorbol-activated and receptor-activated cells remains to be
determined. A third alternative is presented by the interactions
between the N-terminal SH2 domain of p120 and various
proteins containing phosphorylated
tyrosines(19, 25, 54, 55) . The
inhibition in the growth of EBV-transformed B-cells by the
p120 antisense oligonucleotide could result from
interactions between p120 and proteins other than
p190 or p62, the two proteins that are commonly found
in p120 immunoprecipitates. The Src-like tyrosine
kinase Lck is a candidate of particular interest, since Lck forms a
complex in vitro with the phosphorylated N-terminal SH2 domain
of p120 (23) and is thought to play a
significant role in the transformation of EBV-transformed B
lymphocytes(40) . The inhibition of cell growth caused by
p120 antisense oligonucleotides might somehow be
connected to the interaction between p120 and Lck.
FOOTNOTES
- *
- Supported in part by U.S. Public Health Service
Grants AI-24227 and AI-28479. The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore by hereby marked ``advertisement'' in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- §
- Recipient of a Postdoctoral Fellowship from the
Deutsche Forschungsgemeinschaft.
- (
) - The
abbreviations used are: EBV, Epstein-Barr virus; phorbol, phorbol
myristate acetate; HBSS, Hanks' balanced salts solution without
calcium or magnesium; GFX, GF109203X; DMEM, Dulbecco's modified
Eagle's medium; HPLC, high pressure liquid chromatography; PAGE,
polyacrylamide gel electrophoresis.
- (
) - High
passage cells were refractory to the effects of the antisense
nucleotide.
REFERENCES
- Barbacid, M. (1987) Annu. Rev. Biochem. 156, 779-827
[CrossRef]
- Bourne, H. R., Sanders,
D. A., and McCormick, F. (1991) Nature 348, 117-127
- Mulcahy, L. S., Smith, M.
R., and Stacey, D. W. (1985) Nature 313, 241-243
[CrossRef][Medline]
[Order article via Infotrieve]
- Gibbs, J. B., Marshall,
M. S., Scolnick, E. M., Dixon, R. A. F., and Vogel, U. S. (1990) J. Biol. Chem. 265, 20437-20442
[Abstract/Free Full Text]
- Satoh, T., Nakafuko, M.,
and Kaziro, Y. (1992) J. Biol. Chem. 267, 24149-24152
[Free Full Text]
- Satoh, T., Endo, M.,
Miyajima, A., and Kaziro, Y. (1991) Proc. Natl. Acad.
Sci. U. S. A. 88, 3314-3318
[Abstract/Free Full Text]
- Downward, J., Graves, J.
D., Warne, P. H., Rayter, S., and Cantrell, D. A. (1990) Nature 346, 719-723
[CrossRef][Medline]
[Order article via Infotrieve]
- Puil, L., and Pawson, T. (1992) Curr. Biol. 2, 275-279
[CrossRef][Medline]
[Order article via Infotrieve]
- Bowtell, D., Fu, P.,
Simon, M., and Senior, D. (1992) Proc. Natl. Acad.
Sci. U. S. A. 89, 6511-6518
[Abstract/Free Full Text]
- De Clue, J. E.,
Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W.
C., and Lowy, D. R. (1992) Cell 69, 265-273
[CrossRef][Medline]
[Order article via Infotrieve]
- McCormick, F. (1990) Oncogene 5, 1281-1283
[Medline]
[Order article via Infotrieve]
- McCormick, F. (1989) Cell 56, 5-8
[CrossRef][Medline]
[Order article via Infotrieve]
- Vogel, U. S., Dixon, R.
A., Schaber, M. D., Diehl, M. S., Marshall, M. S., Scolnick, E. M.,
Sigal, I. S., and Gibbs, J. B. (1988) Nature 335, 90-93
[CrossRef][Medline]
[Order article via Infotrieve]
- Nori, M., Vogel, U. S.,
Gibbs, J. B., and Weber, M. J. (1991) Mol. Cell. Biol. 11, 2812-2818
[Abstract/Free Full Text]
- DeClue, J. E., Zhang,
K., Redford, P., Vass, W. C., and Lowy, D. R. (1991) Mol. Cell. Biol. 11, 2819-2825
[Abstract/Free Full Text]
- Nori, M.,
L'Allemain, G., and Weber, M. J. (1992) Mol.
Cell. Biol. 12, 936-945
[Abstract/Free Full Text]
- Adari, H., Lowy, D. R.,
Willumsen, B. M., Der, C. J., and McCormick, F. (1988) Science 240, 518-521
[Abstract/Free Full Text]
- Sigal, I. S., Gibbs, J.
B., D'Alonzo, J. S., and Scolnick, E. M. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 4725-4729
[Abstract/Free Full Text]
- Bollag, G., and
McCormick, F. (1991) Annu. Rev. Cell Biol. 7, 601-632
[CrossRef]
- Cooper, J. A., and
Howell, B. (1993) Cell 73, 1051-1054
[Medline]
[Order article via Infotrieve]
- Anderson, D., Koch, C.
A., Grey, L., Ellis, C., Moran, M. F., and Pawson, T. (1990) Science 250, 979-982
[Abstract/Free Full Text]
- Park, S., Liu, X.,
Pawson, T., and Jove, R. (1992) J. Biol. Chem. 267, 17194-17200
[Abstract/Free Full Text]
- Amrein, K. E., Flint,
N., Panholzer, B., and Burn, P. (1992) Proc. Natl.
Acad. Sci. U. S. A. 89, 3343-3346
[Abstract/Free Full Text]
- Brott, B. K., Decker,
S., O'Brien, M. C., and Jove, R. (1991) Mol.
Cell. Biol. 11, 5059-5067
[Abstract/Free Full Text]
- Ellis, C., Moran, M.,
McCormick, F., and Pawson, T. (1990) Nature 343, 377-381
[CrossRef][Medline]
[Order article via Infotrieve]
- Moran, M. F., Koch, C.
A., Anderson, D., Ellis, C., England, L., Martin, G. S., and Pawson, T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 8622-8626
[Abstract/Free Full Text]
- Park, S., and Jove, R. (1993) J. Biol. Chem. 268, 25728-25734
[Abstract/Free Full Text]
- Moran, M. F., Polakis,
P., McCormick, F., Pawson, T., and Ellis, C. (1991) Mol. Cell. Biol. 11, 1804-1812
[Abstract/Free Full Text]
- Park, J-W., El Benna,
J., Scott, K. E., Christensen, B. L., Chanock, S. J., and Babior, B. M. (1994) Biochemistry 33, 2907-2911
[CrossRef][Medline]
[Order article via Infotrieve]
- Gold, M. R., Crowley, M.
T., Martin, G. A., McCormick, F., and DeFranco, A. L. (1993) J. Immunol. 150, 377-386
[Abstract]
- Ellis, C., Liu, X.,
Anderson, D., Abraham, N., Veillette, A., and Pawson, T. (1991) Oncogene 6, 895-901
[Medline]
[Order article via Infotrieve]
- Settlemen, J., Albright,
C. F., Foster, L. C., and Weinberg, R. A. (1992) Nature 359, 153-154
[CrossRef][Medline]
[Order article via Infotrieve]
- Dorseuil, O., Vazquez,
A., Lang, P., Bertoglio, J., Gacon, G., and Leca, G. (1992) J. Biol. Chem. 267, 20540-20542
[Abstract/Free Full Text]
- Abo, A., Pick, E., Hall,
A., Totty, N., Teahan, C. G., and Segal, A. W. (1991) Nature 953, 668-670
- Bokoch, G. M., and
Knaus, U. G. (1994) Curr. Opin. Immunol. 6, 98-105
[CrossRef][Medline]
[Order article via Infotrieve]
- Chanock S. J., El Benna,
J., Smith, R. M., and Babior, B. M. (1994) J. Biol.
Chem. 269, 24519-24522
[Free Full Text]
- Heyworth P. G., Knaus,
U. G., Settlemen, J., Curnutte, J. T., and Bokoch, G. M. (1993) Mol. Biol. Cell 4, 1217-1223
[Abstract]
- Thrasher, A., Chetty,
M., Casimir, C., and Segal, A. W. (1992) Blood 80, 1125-1129
[Abstract/Free Full Text]
- Chanock, S. J., Faust,
L. R., Barrett, D., Bizal, C., Maly, F. E., Newburger, P. E., Ruedi, J.
M., Smith, R. M., and Babior, B. M. (1992) Proc. Natl.
Acad, Sci. U. S. A. 89, 10174-10177
[Abstract/Free Full Text]
- Cheung, R. K., and
Dosch, H.-M. (1991) J. Biol. Chem. 266, 8667-8670
[Abstract/Free Full Text]
- Roth, G., Curiel, T.,
and Lacy, J. (1994) Blood 84, 582-587
[Abstract/Free Full Text]
- Park, J-W., Ma, M.,
Ruedi, J. M., Smith, R. M., and Babior, B. M. (1992) J. Biol. Chem. 267, 17327-17332
[Abstract/Free Full Text]
- Trahey, G., Wong, G.,
Halenbeck, R., Rubinfeld, R., Martin, G. A., Ladner, M., Long, C. M.,
Crosier, W. J., Watt, K., Koths, K., and McCormick, F. (1988) Science 242, 1697-1700
[Abstract/Free Full Text]
- Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed., Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY
- Paterson, B. M.,
Roberts, B. E., and Kuff, E. (1977) Proc. Natl. Acad.
Sci. U. S. A. 74, 4370-4374
[Abstract/Free Full Text]
- Stein, C. A., and Cheng,
Y.-C. (1993) Science 261, 1004-1012
[Abstract/Free Full Text]
- Knaus, U. G., Heyworth,
P. G. Kinsella, B. T., Curnutte, J. T., and Bokoch, G. M. (1992) J. Biol. Chem. 267, 23575-23582
[Abstract/Free Full Text]
- Chuang, T. H., Xu, X.,
Knaus, U. G., Hart, M. J., and Bokoch, G. M. (1993) J.
Biol. Chem. 268, 775-778
[Abstract/Free Full Text]
- Lazarus, A. H.,
Kawandri, K., Rapoport, M. J., and Delovitch, T. L. (1993) J. Exp. Med. 778, 1765-1769
- Quinn, M. T., Mullen, M.
L., Jesaitis, A. J., and Linner, J. G. (1992) Blood 79, 1563-1573
[Abstract/Free Full Text]
- Maly, F. E., Quilliam,
L. A. Dorseuil, O., Der, C. J., and Bokoch, G. M. (1994) J. Biol. Chem. 269, 18743-18746
[Abstract/Free Full Text]
- Polakis, P. G.,
Rubinfeld, B., Evans, T., and McCormick, F. (1991) Biochemistry 88, 239-243
- Kazlauskas, A., Ellis,
C., Pawson, T., and Cooper, J. A. (1990) Science 247, 1578-1581
[Abstract/Free Full Text]
- Anderson, D., Koch, C.
A., Grey, L., Ellis, C., Moran, M. F., and Pawson, T. (1990) Science 250, 979-982
- Koch, C. A., Anderson,
D., Moran, M. F., Ellis C., and Pawson, T. (1991) Science 252, 668-674
[Abstract/Free Full Text]
- Pronk, G. J., Polakis,
P., Wong, G., de Vries-Smits, A. M. M., Bos, J., McCormick, F. (1992) Oncogene 7, 389-394
[Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. M. Babior
NADPH Oxidase: An Update
Blood,
March 1, 1999;
93(5):
1464 - 1476.
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|